Full Year 2023 Investor Presentation

14 Investor presentation Full year 2023 Step-up in CAPEX to meet demand for current and future products CAPEX investments DKK billion 48 42 36 9% 7% 7% 30 5% 4% 24 18 12 10 9 8 6 6 6 0 2017 2018 2019 2020 2021 CAPEX Expected CAPEX - CAPEX: Capital expenditure 7% 12 2022 11% 26 ~45 2023 2024E CAPEX to sales ratio Ensure readiness to meet future demands Novo NordiskⓇ • Capital expenditure is expected to be around DKK 45 billion in 2024 Investments reflect both ongoing and future expansions of the supply chain, including previously communicated expansions at core sites The CAPEX to sales ratio is still expected to be low double digit in the coming years

View entire presentation